Table 1.
Control | EAANa | Recoveryb | |
---|---|---|---|
Initial body weight (gm; day 0) | 25.1 ± 0.4 (29) | 24.8 ± 0.5 (42) | |
Weight change (gm; day 3)c | −0.88 ±0.25 (28) | −3.26 ± 0.32 (39)* | |
Resting heart rate (bpm) | 749 ±3 (21) | 732 ± 8 (23) | 759 ± 4 (5) |
rMSSD (μsec) | 836 ±53 (21) | 542 ± 34 (23)* | 728 ± 70 (5) |
GI transit (percentage of small bowel) | 53.3 ± 4.1% (21) | 30.8 ± 2.4% (22)* | 53.4 ± 9.3% (5) |
Bladder weight (mg) | 79.0 ±10.4 (23) | 246.6 ± 23.2 (31)* | 49.6 ± 14.6 (5) |
Stomach weight (mg) | 305.4 ± 13.9 (21) | 443.9 ± 20.6 (24)* | 436.4 ± 11.6 (5)* |
Rest NE (ng/ml) | 3.69 ± 0.96 (9) | 4.89 ± 1.30 (10) | |
Stress NE (ng/ml) | 19.01 ± 1.33 (22) | 5.18 ± 0.76 (24)* | 11.24 ± 2.25 (5) |
All data are mean ± SEM (number of mice). rMSSD, Root mean square of successive differences in heart period, a measure of heart-rate variability; NE, plasma norepinephrine concentration.
p < 0.0001 compared with control mice (Wilcoxon rank sum test).
Except for body weight, data are from experimental days 2–7.
Data are from EAAN mice examined on experimental days 14–27.
Data are from all mice except those killed before experimental day 3.